NewslettersPancreatic Cell News E2F2 Enhances the Chemoresistance of Pancreatic Cancer to Gemcitabine by Regulating the Cell Cycle and Upregulating the Expression of RRM2 By Danielle Corrigan - June 21, 2022 0 The effect of E2F2 on the proliferation and cell cycling of pancreatic cancer cells was analyzed by tissue culture and flow cytometry. [Oncology Letters] Full Article